Technology area: Biotechnology & Pharmaceuticals
13 pending office actions • 10 art units • 13 examiners • 0 of 13 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Danstar Ferment AG has 12 pending office actions in Biotechnology & Pharmaceuticals. The matters are distributed across 12 distinct examiners and 9 distinct art units, creating a prosecution profile with broad examiner exposure and multiple technical examination contexts.
SAIDHA, TEKCHAND is the busiest examiner, with 1 pending matter. The absence of concentration at one examiner means that portfolio management should prioritize consistent support for biological and pharmaceutical claim positions across separate cases. Counsel may also benefit from maintaining a common disclosure and prior-art framework while adapting responses to the art unit and examiner assigned to each application.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (8%) |
| §103 only | 4 (31%) |
| Double-patenting + other | 3 (23%) |
| Multi-statute (no §101) | 5 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAIDHA, TEKCHAND | 1 | 82.9% | +14.0% |
| TSAY, MARSHA M | 1 | 45.5% | +52.8% |
| HEASLEY, MEGHAN CHRISTINE | 1 | 74.5% | +36.3% |
| RONEY, CELESTE A | 1 | 63.0% | +17.4% |
| SPAINE, ROBERT FRANKLIN | 1 | 75.0% | +0.0% |
| CRAIGO, BAHAR ALAWI | 1 | 47.3% | +27.2% |
| PAK, YONG D | 1 | 74.7% | +14.2% |
| KOROTCHKINA, LIOUBOV G | 1 | 29.0% | +64.1% |
| FRONDA, CHRISTIAN L | 1 | 82.5% | +14.3% |
| THOMAS, TIMOTHY P | 1 | 26.3% | +38.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19057293 | LIMITING YEAST-PRODUCED TREHALOSE IN FERMENTATION | SAIDHA, TEKCHAND | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16980250 | INACTIVATED YEAST AND YEAST PRODUCT FOR IMPROVING FERMENTATION YIELD | EPSTEIN, TODD MATTHEW | 88d overdue |
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | KOROTCHKINA, LIOUBOV G | 49d overdue |
| 18026807 | ALPHA-AMYLASE VARIANTS | FRONDA, CHRISTIAN L | 29d overdue |
| 17614267 | COMPOSITION AND METHOD FOR ENHANCING SPORE GERMINATION AND BIOLOGICAL EFFICACY | THOMAS, TIMOTHY P | 4d overdue |
| 18564236 | COMPOSITION AND METHOD FOR BALANCING IMMUNE SYSTEM AND METABOLIC FUNCTION IN HUMAN AND/OR ANIMAL SUBJECTS | SPAINE, ROBERT FRANKLIN | 27d |
| 18849224 | N-TERMINUS ENGINEERING OF INTRACELLULAR POLYPEPTIDES EXPRESSED IN RECOMBINANT EUKARYOTIC HOST CELLS | TSAY, MARSHA M | — |
| 18693766 | FORMULATIONS AND USES OF RESVERATROL | HEASLEY, MEGHAN CHRISTINE | — |
| 18546073 | COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES AND USES THEREOF | CRAIGO, BAHAR ALAWI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | KOROTCHKINA, LIOUBOV G | 49d overdue |
| 18026807 | ALPHA-AMYLASE VARIANTS | FRONDA, CHRISTIAN L | 29d overdue |
| 17614267 | COMPOSITION AND METHOD FOR ENHANCING SPORE GERMINATION AND BIOLOGICAL EFFICACY | THOMAS, TIMOTHY P | 4d overdue |
| 19057293 | LIMITING YEAST-PRODUCED TREHALOSE IN FERMENTATION | SAIDHA, TEKCHAND | — |
| 18849224 | N-TERMINUS ENGINEERING OF INTRACELLULAR POLYPEPTIDES EXPRESSED IN RECOMBINANT EUKARYOTIC HOST CELLS | TSAY, MARSHA M | — |
| 18693766 | FORMULATIONS AND USES OF RESVERATROL | HEASLEY, MEGHAN CHRISTINE | — |
| 18291944 | BIOCONTROL AGENT AND METHOD FOR REDUCING THE OCCURRENCE AND IMPACTS OF APHANOMYCES EUTEICHES | RONEY, CELESTE A | — |
| 18546073 | COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES AND USES THEREOF | CRAIGO, BAHAR ALAWI | — |
| Art Unit | Apps |
|---|---|
| 1652 | 4 |
| 1656 | 1 |
| 1626 | 1 |
| 1612 | 1 |
| 1655 | 1 |
| 1699 | 1 |
| 1653 | 1 |
| 1614 | 1 |
| 1793 | 1 |
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19057293 | LIMITING YEAST-PRODUCED TREHALOSE IN FERMENTATION | SAIDHA, TEKCHAND | 1652 | §112DP | Non-Final OA | — | Pending | Feb 19, 2025 |
| 18849224 | N-TERMINUS ENGINEERING OF INTRACELLULAR POLYPEPTIDES EXPRESSED IN RECOMBINANT EUKARYOTIC HOST CELLS | TSAY, MARSHA M | 1656 | §102§112 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18693766 | FORMULATIONS AND USES OF RESVERATROL | HEASLEY, MEGHAN CHRISTINE | 1626 | §103§112 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18291944 | BIOCONTROL AGENT AND METHOD FOR REDUCING THE OCCURRENCE AND IMPACTS OF APHANOMYCES EUTEICHES | RONEY, CELESTE A | 1612 | §103 | Non-Final OA | — | Pending | Jan 25, 2024 |
| 18564236 | COMPOSITION AND METHOD FOR BALANCING IMMUNE SYSTEM AND METABOLIC FUNCTION IN HUMAN AND/OR ANIMAL SUBJECTS | SPAINE, ROBERT FRANKLIN | 1655 | §101§103 | Final Rejection | 27d | Pending | Nov 27, 2023 |
| 18546073 | COMPOSITIONS COMPRISING EXOPOLYSACCHARIDES AND USES THEREOF | CRAIGO, BAHAR ALAWI | 1699 | §102§103§112 | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18355776 | METHODS FOR THE IMPROVEMENT OF PRODUCT YIELD AND PRODUCTION IN A MICROORGANISM THROUGH GLYCEROL RECYCLING | PAK, YONG D | 1652 | §102§103§112DP | Non-Final OA | — | Pending | Jul 20, 2023 |
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | KOROTCHKINA, LIOUBOV G | 1653 | §103§112DP | Non-Final OA | 49d overdue | Pending | Jul 12, 2023 |
| 18026807 | ALPHA-AMYLASE VARIANTS | FRONDA, CHRISTIAN L | 1652 | §103§112Other | Final Rejection | 29d overdue | Pending | Mar 16, 2023 |
| 17614267 | COMPOSITION AND METHOD FOR ENHANCING SPORE GERMINATION AND BIOLOGICAL EFFICACY | THOMAS, TIMOTHY P | 1614 | §103 | Non-Final OA | 4d overdue | Pending | Nov 24, 2021 |
| 17372332 | PROCESS FOR MODULATING THE NUTRITIONAL VALUE OF WHOLE STILLAGE AND DISTILLERS PRODUCTS ASSOCIATED THERETO | TURNER, FELICIA C | 1793 | §103 | Final Rejection | 46d overdue | Pending | Jul 09, 2021 |
| 17316051 | METHODS FOR THE IMPROVEMENT OF PRODUCT YIELD AND PRODUCTION IN A MICROORGANISM THROUGH THE ADDITION OF ALTERNATE ELECTRON ACCEPTORS | MISHRA, DEEPA | 1657 | §103 | Final Rejection | 29d overdue | Pending | May 10, 2021 |
| 16980250 | INACTIVATED YEAST AND YEAST PRODUCT FOR IMPROVING FERMENTATION YIELD | EPSTEIN, TODD MATTHEW | 1652 | §103§112 | Non-Final OA | 88d overdue | Pending | Sep 11, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDanstar Ferment AG has 13 pending office actions as of October 2026, spread across 10 art units and 13 examiners.
Tekchand Saidha has the most, with 1 of Danstar Ferment AG's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
